Institution statistics

EUROPEAN VACCINE INITIATIVE - EEIG - Germany 

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:70
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding:800-900
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding:800-900
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:200-300
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 10
As coordinator: 4
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0.67*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2013 4.647.149 11.930.177 1.961.930 1 3
2012 0 6.000.000 1.200.000 1
2010 0 10.300.000 250.000 1
2009 11.832.334 300.000 924.662 3 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
FOUNDATION BIOMEDICAL PRIMATE RESEARCH CENTRE5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD5
WORLD HEALTH ORGANIZATION3
DEPARTMENT OF HEALTH2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
HEALTH PROTECTION AGENCY2
IDLELYSTAD INSTITUUT VOOR DIERHOUDERIJ EN DIERGEZONDHEID BV2
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE2
PROGRAM FOR APPROPRIATE TECHNOLOGYIN HEALTH2
STATENS SERUM INSTITUT2
STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK2
STICHTING TUBERCULOSIS VACCINE INITIATIVE2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS LEIDEN1
AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES1
BRIGHTON COLLABORATION FOUNDATION1
CENTRE DE RECHERCHES MEDICALES DE LAMBARENE1
COLLEGE OF MEDICINE UNIVERSITY OF IBADAN1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ETNA BIOTECH S R L1
EUROVACC FOUNDATION1
EXPRES2ION BIOTECHNOLOGIES APS1
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES1
FONDATION INTERNATIONAL DE L'HOPITAL DE DR ALBERT SCHWEITZER DE LAMBARENE1
FONDATION MERIEUX1
FUNDACIO CENTRE DE RECERCA EN SALUT INTERNATIONAL DE BARCELONA1
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG1
HOSPICES CANTONAUX CHUV1
IFAKARA HEALTH INSTITUTE TRUST1
IMAXIO1
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUT PASTEUR1
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA1
ISTITUTO NAZIONALE MALATTIE INFETTIVE LSPALLANZANI IRCCS1
KENYA MEDICAL RESEARCH INSTITUTE1
LIONEX1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
MALARIA CONSORTIUM LBG1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MEDICAL RESEARCH COUNCIL1
NATIONAL INSTITUTE FOR MEDICAL RESEARCH1
NOVARTIS VACCINES AND DIAGNOSTICS1
OKAIROS1
PATRICE MARTIN DUBOIS IMMUNOVACC CONSULTING1
PRECLIN BIOSYSTEMS1
REDBIOTEC1
SCLAVO VACCINES ASSOCIATION1
STICHTING EATRIS1
STICHTING KATHOLIEKE UNIVERSITEIT1
STOCKHOLMS UNIVERSITET1
SWISS TROPICAL INSTITUTE1
THE UNIVERSITY OF EDINBURGH1
UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES1
UNIVERSITAET REGENSBURG1
UNIVERSITE D'ABOMEYCALAVI1
UNIVERSITE DE GENEVE1
UNIVERSITE DE LAUSANNE1
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI1
UNIVERSITY OF COPENHAGEN1
VACCINE AND GENE THERAPY INSTITUTE OF FLORIDA CORP1
VAKZINE PROJEKT MANAGEMENT1
Constancy:

Total number of partners:81

Partner loyalty:
Frequent Partner: (> 2 projects): 13
Rare Partner: 68

Frequent / Rare Partner Ratio: 0.19

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES7
RTD HORIZONTAL TOPICS4

Project overview:

Start dateProjectacronymrolefundingpartners
2013-12-01Innovation Partnership for a Roadmap on Vaccines in Europe IPROVEparticipant496.3674
2013-11-01Combinatorial immunization strategy to educate the immune system towards cross recognition and coverage against antigenic drift in seasonal influenza virus exposure EDUFLUVACcoordinator4.647.1497
2013-09-01comBinig cELLular and humoral immunE RespOnses as a vaccine strategy against staPHhylOcoccus aureus pathogeN BELLEROPHONparticipant5.498.8294
2013-03-01Clinical development of a VAR2CSA-based placental malaria vaccine PLACMALVACparticipant5.934.9816
2012-10-01A Multi-Stage Malaria Vaccine MULTIMALVAXparticipant6.000.0005
2010-03-01Dissecting the Immunological Interplay between Poverty Related Diseases and Helminth Infections: An African-European Research Initiative IDEAparticipant10.300.00023
2009-11-01Platform for the Harmonization of Vaccine Adjuvant Testing PHARVATparticipant300.0003
2009-10-01European Network of Vaccine Development and Research TRANSVACcoordinator9.899.99915
2009-04-01Initiative on optimizing malaria vaccine lab assays evaluation OPTIMALVACcoordinator1.000.00014
2009-02-01Optimisation of the development of Poverty-Related-Diseases (PRD) vaccines by a transversal approach, addressing common gaps and challenges INYVAXcoordinator932.33510

Alias institution names:
  • EUROPEAN VACCINE INITIATIVE EEIG

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum